Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-133024
Filing Date
2016-07-18
Accepted
2016-07-18 16:09:22
Documents
1
Period of Report
2016-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5677
  Complete submission text file 0001209191-16-133024.txt   7272
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD CO 80112
Business Address
Donofrio John Jr. (Reporting) CIK: 0001679841 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53121 | Film No.: 161771665